110 related articles for article (PubMed ID: 27105574)
1. TGF-β induces SOX2 expression in a time-dependent manner in human melanoma cells.
Weina K; Wu H; Knappe N; Orouji E; Novak D; Bernhardt M; Hüser L; Larribère L; Umansky V; Gebhardt C; Utikal J
Pigment Cell Melanoma Res; 2016 Jul; 29(4):453-8. PubMed ID: 27105574
[TBL] [Abstract][Full Text] [Related]
2. SOX2 and nestin expression in human melanoma: an immunohistochemical and experimental study.
Laga AC; Zhan Q; Weishaupt C; Ma J; Frank MH; Murphy GF
Exp Dermatol; 2011 Apr; 20(4):339-45. PubMed ID: 21410764
[TBL] [Abstract][Full Text] [Related]
3. Repression of TIF1γ by SOX2 promotes TGF-β-induced epithelial-mesenchymal transition in non-small-cell lung cancer.
Wang L; Yang H; Lei Z; Zhao J; Chen Y; Chen P; Li C; Zeng Y; Liu Z; Liu X; Zhang HT
Oncogene; 2016 Feb; 35(7):867-77. PubMed ID: 25961934
[TBL] [Abstract][Full Text] [Related]
4. Melanoma-associated expression of transforming growth factor-beta isoforms.
Van Belle P; Rodeck U; Nuamah I; Halpern AC; Elder DE
Am J Pathol; 1996 Jun; 148(6):1887-94. PubMed ID: 8669474
[TBL] [Abstract][Full Text] [Related]
5. Autocrine TGF-beta signaling maintains tumorigenicity of glioma-initiating cells through Sry-related HMG-box factors.
Ikushima H; Todo T; Ino Y; Takahashi M; Miyazawa K; Miyazono K
Cell Stem Cell; 2009 Nov; 5(5):504-14. PubMed ID: 19896441
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of Lerk-5/Eplg5 messenger RNA: a novel marker for increased tumorigenicity and metastatic potential in human malignant melanomas.
Vogt T; Stolz W; Welsh J; Jung B; Kerbel RS; Kobayashi H; Landthaler M; McClelland M
Clin Cancer Res; 1998 Mar; 4(3):791-7. PubMed ID: 9533549
[TBL] [Abstract][Full Text] [Related]
7. SOX2 regulates self-renewal and tumorigenicity of human melanoma-initiating cells.
Santini R; Pietrobono S; Pandolfi S; Montagnani V; D'Amico M; Penachioni JY; Vinci MC; Borgognoni L; Stecca B
Oncogene; 2014 Sep; 33(38):4697-708. PubMed ID: 24681955
[TBL] [Abstract][Full Text] [Related]
8. A signal transduction pathway from TGF-β1 to SKP2 via Akt1 and c-Myc and its correlation with progression in human melanoma.
Qu X; Shen L; Zheng Y; Cui Y; Feng Z; Liu F; Liu J
J Invest Dermatol; 2014 Jan; 134(1):159-167. PubMed ID: 23792459
[TBL] [Abstract][Full Text] [Related]
9. In situ expression of transforming growth factor beta is associated with melanoma progression and correlates with Ki67, HLA-DR and beta 3 integrin expression.
Moretti S; Pinzi C; Berti E; Spallanzani A; Chiarugi A; Boddi V; Reali UM; Giannotti B
Melanoma Res; 1997 Aug; 7(4):313-21. PubMed ID: 9293481
[TBL] [Abstract][Full Text] [Related]
10. Transcriptional regulation of seprase in invasive melanoma cells by transforming growth factor-β signaling.
Tulley S; Chen WT
J Biol Chem; 2014 May; 289(22):15280-96. PubMed ID: 24727589
[TBL] [Abstract][Full Text] [Related]
11. Macrophage migration inhibitory factor protein and mRNA expression in cutaneous melanocytic tumours.
Miracco C; De Nisi MC; Arcuri F; Cosci E; Pacenti L; Toscano M; Lalinga AV; Biagioli M; Rubegni P; Vatti R; Maellaro E; Del Bello B; Massi D; Luzi P; Tosi P
Int J Oncol; 2006 Feb; 28(2):345-52. PubMed ID: 16391788
[TBL] [Abstract][Full Text] [Related]
12. Patterns of melastatin mRNA expression in melanocytic tumors.
Deeds J; Cronin F; Duncan LM
Hum Pathol; 2000 Nov; 31(11):1346-56. PubMed ID: 11112208
[TBL] [Abstract][Full Text] [Related]
13. Apaf-1 expression in human cutaneous melanoma progression and in pigmented nevi.
Niedojadło K; Łabedzka K; Łada E; Milewska A; Chwirot BW
Pigment Cell Res; 2006 Feb; 19(1):43-50. PubMed ID: 16420245
[TBL] [Abstract][Full Text] [Related]
14. Expression of the embryonic stem cell transcription factor SOX2 in human skin: relevance to melanocyte and merkel cell biology.
Laga AC; Lai CY; Zhan Q; Huang SJ; Velazquez EF; Yang Q; Hsu MY; Murphy GF
Am J Pathol; 2010 Feb; 176(2):903-13. PubMed ID: 20042675
[TBL] [Abstract][Full Text] [Related]
15. The effect of the sun on expression of beta-catenin, p16 and cyclin d1 proteins in melanocytic lesions.
Demirkan NC; Kesen Z; Akdag B; Larue L; Delmas V
Clin Exp Dermatol; 2007 Nov; 32(6):733-9. PubMed ID: 17868395
[TBL] [Abstract][Full Text] [Related]
16. [Expression of galanin in melanocytic tumors].
Gilaberte Y; Vera J; Coscojuela C; Roca MJ; Parrado C; González S
Actas Dermosifiliogr; 2007; 98(1):24-34. PubMed ID: 17374330
[TBL] [Abstract][Full Text] [Related]
17. Cyclin D1 expression in melanocytic lesions of the skin.
Ramirez JA; Guitart J; Rao MS; Diaz LK
Ann Diagn Pathol; 2005 Aug; 9(4):185-8. PubMed ID: 16084449
[TBL] [Abstract][Full Text] [Related]
18. Cytoplasmic beta-catenin is lacking in a subset of melanoma-associated naevi, but is detectable in naevus-associated melanomas: potential implications for melanoma tumorigenesis?
De Panfilis G; Ferrari D; Santoro S; Ricci R; Lombardi M; Pedrazzi G; Pepe C; Cortelazzi C; Santini M
Br J Dermatol; 2009 Mar; 160(3):600-8. PubMed ID: 19183173
[TBL] [Abstract][Full Text] [Related]
19. Independent regulation of growth and SMAD-mediated transcription by transforming growth factor beta in human melanoma cells.
Rodeck U; Nishiyama T; Mauviel A
Cancer Res; 1999 Feb; 59(3):547-50. PubMed ID: 9973198
[TBL] [Abstract][Full Text] [Related]
20. Human melanoma cells express functional receptors for thyroid-stimulating hormone.
Ellerhorst JA; Sendi-Naderi A; Johnson MK; Cooke CP; Dang SM; Diwan AH
Endocr Relat Cancer; 2006 Dec; 13(4):1269-77. PubMed ID: 17158770
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
